Company Overview
Pykus Therapeutics Inc. is a clinical stage medical technology company developing biodegradable polymers to provide solutions for unmet needs in vitreoretinal surgery. Pykus was founded in 2016 and is led by a team of committed physicians, scientists, engineers, and entrepreneurs. Our lead product, PYK-2101, is a novel biodegradable hydrogel that allows patients to recover from retina surgery faster and more comfortably.
